ANGPTL3 and systemic sclerosis: In addition to that, ANGPTL3 has been shown in vivo to be negatively regulated by thyroid hormone (47) and serum ANGPTL3 levels have been reported to be significantly higher in patients with rheumatic disorders, including dermatomyositis and systemic sclerosis (48).